The ABPI has come out on top in the opening salvo of its unprecedented European legal challenge against prescribing incentive …
Research funded by the Chartered Institue of Management Accountants (CIMA) has helped Cranfield School of Management unveil a new framework …

GlaxoSmithKline has appointed Adrian Hodges to head up corporate responsibility and community partnerships. He moves to the pharma company after …

The British Medical Association is urging the public to resist the role of private companies in the NHS. Its Look …
MDS has completed the sell-off of its contract research and development business – MDS Pharma Services – with the signing …

NICE has given a partial green light to Novo Nordisk’s type II diabetes treatment Victoza, backing its use as part …
Sanofi-Aventis has expanded its My Child Matters programme, adding another seven new projects for improving cancer care for children in …
Jan van Heek has joined Amarin’s board of directors of as a non-executive director and will also take on the role …
Our round-up of developments in the contract research sector includes alliances for Parexel/Proteome Sciences and SIRO Clinpharm/DreamCIS, as well as …

Langland has marshaled its digital and design teams in support of Bliss, producing a pro bono campaign for the premature …

US–based specialty pharma company Cephalon, best known for its sleep disorder treatment Provigil, has posted an 11% increase in sales …

The MHRA is considering putting its database of patient information leaflets (PILs) and Summaries of Product Characteristics (SPCs) online and …
The market for ulcerative colitis drugs is set to double over the ten years to 2018 when it will hit …
A new review of UK health services has come up with half a dozen ways in which the government should …
Business advisory firm Deloitte has made three senior appointments to its UK Life Sciences & Health Care practice. Julian Remnant …
Management Forum is pleased to announce the launch of their PHARMACY 2010 Exhibition website. This exciting new website contains full …
The healthcare industry is changing. In pharma, the new rising commercial leaders, business unit heads, marketing managers, have both business …
Sanofi-Aventis made large gains in emerging markets, vaccines and consumer healthcare last year, helping produce 8.5 billion euros in net …
Phase III results for Roche’s once-weekly injectable drug taspoglutide have shown a positive effect on reducing blood glucose compared with …
AstraZeneca’s chief executive David Brennan has rejected the strategy of diversification into generics and biosimilars being pursued by many of …